Find your next paid study

Emory UniversityNCT07428746

~$50 – $1,500

Actual pay is set by the research site.

Thromboangiitis Obliterans (Buerger's Disease)

A First in Human, Double-Blind, Placebo-Controlled, Randomized Evaluation of Single Ascending Doses of ATI-1013, a Human Monoclonal Antibody to Nicotine in Healthy Smokers

This study is a first-in-human clinical trial of drug ATI-1013, in healthy adult cigarette smokers. The main questions it aims to answer are to learn about the…

Antidote Therapeutics, IncNCT07215923

~$500 – $10,500

Actual pay is set by the research site.

Testing of an Educational Tool for Patients With Melanoma and Concomitant Autoimmune Disease Who Are Candidates for Adjuvant Therapy With Immune Checkpoint Inhibitors: Acceptability and Usability With Patients and Providers

This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who recei…

Ankylosing SpondylitisAutoimmune DiseaseCrohn Disease+10 more

M.D. Anderson Cancer CenterNCT04751396

Actual pay is set by the research site.

Neovascular (Wet) Age-Related Macular Degeneration

A Phase 1/2 Dose-Escalation and Randomized, Controlled, Masked Expansion Trial of Intravitreal 4D-150 Gene Therapy in Adults With Neovascular (Wet) Age-Related Macular Degeneration

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will eva…

4D Molecular TherapeuticsNCT05197270

~$150 – $4,200

Actual pay is set by the research site.

Observational

Enhancing Brain and Mental Health Through Respiratory Training: Clinical Applications in Cancer and Neurodegenerative Disease Care for Patients and Caregivers (Breathing Study)

This clinical trial studies the effect of respiratory training for enhancing brain and mental health among patients with multiple sclerosis (MS) and cancer (al…

Malignant Brain NeoplasmMalignant Solid NeoplasmMultiple Sclerosis+2 more

Actual pay is set by the research site.

Mayo ClinicNCT06788886

HypophosphatemiaRicketsHypercalciuria+2 more

The Impact of Phosphate Metabolism on Healthy Aging

Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial…

Yale UniversityNCT03771105

~$150 – $3,000

Actual pay is set by the research site.

Observational

Thermogenic Responses to Fasting and Overfeeding in Women: a Potential Mechanism Contributing to Postmenopausal Weight Gain

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The…

Obesity

University of Colorado, DenverNCT06610162

Actual pay is set by the research site.

Observational

Enhancing the Implementation of Tobacco Treatment: A Community-responsive Approach

The goal of this study is to: partner with Respiratory Health Association and determine barriers and unmet smoking cessation treatment needs from leaders in be…

Nicotine Use DisorderSmoking CessationSmoking Cessation Intervention

University of ChicagoNCT06837220

Actual pay is set by the research site.

Phase 2

A Randomized Phase 2, Open-label Study of Mirvetuximab Soravtansine in Patients With Platinum-resistant Advanced High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-alpha Expression Testing 2 Schedules of Administration for Dose Optimization, With a Separate Cohort to Determine Starting Dose in Patients With Moderate Hepatic Impairment

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the safety and efficacy …

Advanced High-Grade Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancers

Ulcerative ColitisCrohn's Disease

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT06682988

Phase 3

An Open-Label, Phase 3 Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of Vedolizumab Subcutaneous in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy

The main aim of this study is to learn how the body of a child or teenager with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) p…

~$50 – $2,250

Actual pay is set by the research site.

TakedaNCT06100289

Spasticity, MuscleMicrocephalyIntellectual Deficiency+3 more

A Phase 1/2 Open-label Intrathecal Administration of MELPIDA to Determine Its Safety and Efficacy for Patients With Spastic Paraplegia Type 50 (SPG50) Caused by Mutation in the AP4M1 Gene.

MELPIDA is proposed for the treatment of subjects with SPG50 and targets neuronal cells to deliver a fully functional human AP4M1 cDNA copy via intrathecal inj…

Elpida Therapeutics SPCNCT05518188

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial

Chronic pain symptoms are very common among U.S. Military Veterans and have a profound negative impact on mental health symptoms and quality of life, in additi…

Chronic Low Back Pain